A Study of Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic Melanoma
Clinical trial NCT03153085 · COMPLETED
Trial details
- NCT number
- NCT03153085
- Sponsor
- Takara Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2018-06-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.